ARCHIVES

Clinical Trials Approved By NCI Last Month Are Listed

This article is from The Cancer Letter archive.

Vol. 26 No. 8 | August 29, 2003

Download PDF Visit The Full Archive

Related Articles

NCI Plans Brain Tumor Study To Determine Risk Factors, Exposures

April 16, 1993

Zometa Reduced Bone Complications In Patients With Prostate Cancer Bone Mets

October 25, 2002

House Committee Gives NCI Only $6.5 Million Over President’s request

July 28, 1989

Regorafenib Trial Meets Primary Endpoint; Overall Survival Improved by 29 Percent

January 27, 2012

ASCO Strategic Plan Seeks To Increase Value to Members, Public

May 24, 2002

New ESA Label Maintains 12 g/dL

November 9, 2007